I understand the anxiety, but from a scientific standpoint the main concern is ensuring that any edits are precise and safe. CRISPR is powerful, but off‑target effects can still occur, especially when editing germline cells. Regulators need to enforce rigorous testing and validation before clinical use. It isn’t about restricting freedom so much as preventing unintended consequences that could harm future generations. If we set proper safety protocols and transparency, the technology can still advance responsibly.